HC Wainwright & Co. Reiterates Buy on AEON Biopharma, Maintains $18 Price Target

Benzinga · 05/06 10:44
HC Wainwright & Co. analyst Douglas Tsao reiterates AEON Biopharma (AMEX:AEON) with a Buy and maintains $18 price target.